Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:742-747
Published online before print January 20, 2005, doi: 10.1161/01.ATV.0000156288.70849.26
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
25/4/742    most recent
01.ATV.0000156288.70849.26v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Park, K.-W.
Right arrow Articles by Kim, H.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Park, K.-W.
Right arrow Articles by Kim, H.-S.
Related Collections
Right arrow Restenosis
Right arrow Smooth muscle proliferation and differentiation
Right arrow Gene therapy
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:742.)
© 2005 American Heart Association, Inc.


Vascular Biology

Activated Forkhead Transcription Factor Inhibits Neointimal Hyperplasia After Angioplasty Through Induction of p27

Kyung-Woo Park; Dae-Hee Kim; Hyun-Jung You; Jung-Ju Sir; Soo-In Jeon; Seock-Won Youn; Han-Mo Yang; Carsten Skurk; Young-Bae Park; Kenneth Walsh; Hyo-Soo Kim

From Cardiovascular Laboratory (K.-W.P., D.-H.K., H.-J.Y., J.-J.S., S.-I.J., S.-W.Y., H.-M.Y., Y.-B.P., H.-S.K.), Clinical Research Institute, Seoul National University Hospital; Whitaker Cardiovascular Institute (C.S., K.W.), Boston University School of Medicine, Boston, Mass; Department of Internal Medicine (J.-J.S., Y.-B.P., H.-S.K.), Seoul National University College of Medicine, Seoul, Korea.

Correspondence to Hyo-Soo Kim, MD, PhD, Department of Internal Medicine, Seoul National University College of Medicine, 28 Yongon-dong Chongno-gu, Seoul 110-744, Korea. E-mail hyosoo{at}snu.ac.kr

Objective— We examined the effects of FKHRL1 (forkhead transcription factor in rhabdomyosarcoma like-1) overexpression on vascular smooth muscle cell (VSMC) proliferation, apoptosis, and cell cycle, in vitro, and the role of FKHRL1 and p27 in the pathophysiology of neointimal growth after balloon angioplasty, in vivo. Furthermore, we tested whether FKHRL1 overexpression can inhibit neointimal hyperplasia in a rat carotid artery model.

Methods and Results— Adenovirus expressing the constitutively active FKHRL1 (FKHRL1-TM; triple mutant) with 3 Akt phosphorylation sites mutated was transfected to subconfluent VSMCs. FKHRL1 overexpression in cultured VSMCs increased p27 expression, leading to G1 phase cell-cycle arrest and increased apoptosis. In vivo, the phosphorylation of FKHRL1 increased significantly 3 hours after balloon injury and decreased thereafter, with the subsequent downregulation of p27. Although the phosphorylation of FKHRL1 was greatest at 3 hours, the downregulation of p27 showed a temporal delay, only slightly starting to decrease after 3 hours and reaching a nadir at 72 hours after balloon injury. Gene transfer of FKHRL1-TM increased p27, decreased proliferation, and increased apoptosis of VSMCs, which resulted in a marked reduction in neointima formation (intima-to-media ratio: 0.31±0.13 versus 1.17±0.28, for FKHRL1-TM versus Adv-GFP; P<0.001).

Conclusion— Balloon angioplasty leads to the phosphorylation of FKHRL1 and decreased expression of p27, thereby promoting a proliferative phenotype in VSMCs in vitro and in vivo. This study reveals the importance of FKHRL1 in proliferation and viability of VSMCs and suggests that it may serve as a molecular target for interventions to reduce neointima formation after angioplasty.

The role of FKHRL1 (forkhead transcription factor in rhabdomyosarcoma like-1) in VSMC biology and in neointimal hyperplasia after balloon angioplasty has not been studied. Here, we show that the inactivation of the forkhead transcription factor is required for neointimal hyperplasia after angioplasty, and that overexpression of FKHRL1 leads to the induction of p27 resulting in inhibition of neointimal hyperplasia.


Key Words: forkhead transcription factors • neointima • p27 • vascular smooth muscle cell




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
J.-Y. Kim, H.-J. Cho, J.-J. Sir, B.-K. Kim, J. Hur, S.-W. Youn, H.-M. Yang, S.-I. Jun, K.-W. Park, S.-J. Hwang, et al.
Sulfasalazine induces haem oxygenase-1 via ROS-dependent Nrf2 signalling, leading to control of neointimal hyperplasia
Cardiovasc Res, June 1, 2009; 82(3): 550 - 560.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Allard, N. Figg, M. R. Bennett, and T. D. Littlewood
Akt Regulates the Survival of Vascular Smooth Muscle Cells via Inhibition of FoxO3a and GSK3
J. Biol. Chem., July 11, 2008; 283(28): 19739 - 19747.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H.-Y. Lee, H.-J. You, J.-Y. Won, S.-W. Youn, H.-J. Cho, K.-W. Park, W.-Y. Park, J.-S. Seo, Y.-B. Park, K. Walsh, et al.
Forkhead Factor, FOXO3a, Induces Apoptosis of Endothelial Cells Through Activation of Matrix Metalloproteinases
Arterioscler. Thromb. Vasc. Biol., February 1, 2008; 28(2): 302 - 308.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. N. Papanicolaou, Y. Izumiya, and K. Walsh
Forkhead Transcription Factors and Cardiovascular Biology
Circ. Res., January 4, 2008; 102(1): 16 - 31.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. Nakamura, S.-i. Yamagishi, T. Matsui, T. Yoshida, K. Takenaka, Y. Jinnouchi, Y. Yoshida, S.-i. Ueda, H. Adachi, and T. Imaizumi
Pigment Epithelium-Derived Factor Inhibits Neointimal Hyperplasia after Vascular Injury by Blocking NADPH Oxidase-Mediated Reactive Oxygen Species Generation
Am. J. Pathol., June 1, 2007; 170(6): 2159 - 2170.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. D. Littlewood and M. R. Bennett
Foxing Smooth Muscle Cells: FOXO3a-CYR61 Connection
Circ. Res., February 16, 2007; 100(3): 302 - 304.
[Full Text] [PDF]


Home page
Circ. Res.Home page
H.-Y. Lee, J.-W. Chung, S.-W. Youn, J.-Y. Kim, K.-W. Park, B.-K. Koo, B.-H. Oh, Y.-B. Park, B. Chaqour, K. Walsh, et al.
Forkhead Transcription Factor FOXO3a Is a Negative Regulator of Angiogenic Immediate Early Gene CYR61, Leading to Inhibition of Vascular Smooth Muscle Cell Proliferation and Neointimal Hyperplasia
Circ. Res., February 16, 2007; 100(3): 372 - 380.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. Li, C. Zhang, S. Schaefer, A. Estes, and K. U. Malik
ANG II-induced neointimal growth is mediated via cPLA2- and PLD2-activated Akt in balloon-injured rat carotid artery
Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2592 - H2601.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Md. R. Abid, K. Yano, S. Guo, V. I. Patel, G. Shrikhande, K. C. Spokes, C. Ferran, and W. C. Aird
Forkhead Transcription Factors Inhibit Vascular Smooth Muscle Cell Proliferation and Neointimal Hyperplasia
J. Biol. Chem., August 19, 2005; 280(33): 29864 - 29873.
[Abstract] [Full Text] [PDF]